Loading resource…

Edward J Benz, Jr, MD, Emanuele Angelucci, MD
The management of thalassemia syndromes can be challenging due to numerous potential disease complications and the limited available therapies, primarily transfusion and hematopoietic cell transplantation. This review covers the management strategies for both alpha and beta thalassemias, including transfusion-dependent and transfusion-independent forms. It also highlights the importance of monitoring and addressing complications associated with the disease, as well as the need for genetic counseling for affected individuals.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Myeloproliferative Neoplasms
Same clinical topic · Hematology

MASTOCYTOSIS
Same clinical topic · Hematology

MYELODYSPLASTIC SYNDROMES: 2023 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT
Same clinical topic · Hematology

PERIPHERAL T-CELL LYMPHOMAS
Same clinical topic · Hematology

COMPARISON OF THE INTERNATIONAL CONSENSUS AND 5TH WHO EDITION CLASSIFICATIONS OF ADULT MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
Same clinical topic · Hematology

VEXAS SYNDROME: A COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, AND THERAPEUTIC STRATEGIES
Same clinical topic · Hematology

IRON DEFICIENCY
Same clinical topic · Hematology

MULTIPLE MYELOMA: 2026 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION AND MANAGEMENT
Same clinical topic · Hematology

ANTIDOTES FOR ANTICOAGULATION REVERSAL
Same clinical topic · Hematology